The project reported in this Occasional Paper was intended to determine how changing demands for evidence are affecting drug development in five global pharmaceutical companies: Amgen, Eli Lilly, GSK, Novartis and Sanofi-Aventis. Read more here. (Source: OHE, 4/23/14).
You are here: Home / Industry News / How Will Demands For Effectiveness Evidence Change Drug Development